Sanomedics, Inc. Receivables Turnover Ratio (SIMH), from the third quarter 2015 to the third quarter 2014 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Sanomedics, Inc.  (SIMH)
 

Sanomedics Accounts Receivables Turnover Ratio from the third quarter 2015 to the third quarter 2014

Quarterly Results, Trends, Rankings, Statistics


Sanomedics, Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2015 to a ratio of 6.73, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the third quarter 2015. Average receivable collection period, for the Sanomedics in Sep 30 2015 quarter, has decreased to 54 days, compared to 57 days, in the Jun 30 2015 quarter.

If we take a look into Healthcare sector 243 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2622, from overall ranking in the second quarter 2015 at 2794.

What is Receivable Turnover Ratio?
What is Sanomedics, Inc. Selling?


What is Receivable Turnover Ratio?





SIMH Receivables Turnover Ratio (Sep 30 2015)
III. Quarter
(Jun 30 2015)
II. Quarter
(Mar 31 2015)
I. Quarter
(Dec 31 2014)
IV. Quarter
(Sep 30 2014)
III. Quarter
Y / Y Receivable Change -72.38 % 38.6 % 183.67 % 1158.61 % -96.45 %
Y / Y Revenue Change 0.96 % 118.98 % 33.85 % - -78.56 %
Receivable Turnover Ratio (TTM) 6.73 6.43 6.04 7.2 0.42
SIMH's Total Ranking # 2622 # 2794 # 2954 # 2289 # 4202
Accounts Receivable average collection period days 54 57 60 51 864
Seq. Receivable Change -87.01 % -59.32 % -33.51 % 685.96 % -34.81 %
Seq. Revenue Change -34.62 % -26.23 % -50.22 % 320.54 % 41.8 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 73
Healthcare Sector # 244
Overall Market # 2622

Receivable Turnover Ratio Statistics
High Average Low
16.57 6.54 0.42
(Jun 30 2012)   (Sep 30 2014)






Financial Statements
Sanomedics's Accounts Receivable $ 0 Millions Visit SIMH's Balance sheet
Sanomedics's Sales TTM $ 1 Millions Visit SIMH's Income Statement
Sources of SIMH's Revenues Visit SIMH's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SIMH's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SIMH's Growth Rates SIMH's Roa SIMH's Inventory Turnover Ratio SIMH's Dividend Comparisons
SIMH's Profitability Ratios SIMH's Roi SIMH's Asset Turnover Ratio SIMH's Dividend Growth
SIMH's Valuation Ratios SIMH's Roe SIMH's Financial Strength Ratios SIMH's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2015, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2015 Receivable at quarter ending Sep 30 2015
Infinity Pharmaceuticals Inc   250.82 $ 104.342  Millions$ 0.416  Millions
Diversicare Healthcare Services Inc   235.39 $ 377.802  Millions$ 1.605  Millions
China Yct International Group, Inc.  233.99 $ 46.698  Millions$ 0.200  Millions
U S Physical Therapy Inc  210.44 $ 323.968  Millions$ 1.540  Millions
Fibrocell Science, Inc.  186.40 $ 0.466  Millions$ 0.003  Millions
China Biologic Products Holdings Inc   127.00 $ 286.161  Millions$ 2.253  Millions
Earth Science Tech Inc   122.87 $ 0.271  Millions$ 0.002  Millions
Dna Testing Centers Corp  114.82 $ 0.005  Millions$ 0.000  Millions
Novaccess Global Inc  99.71 $ 1.216  Millions$ 0.012  Millions
Concert Pharmaceuticals Inc   98.23 $ 57.734  Millions$ 0.588  Millions
Reliv International Inc  93.58 $ 53.564  Millions$ 0.572  Millions
Dariohealth Corp   90.56 $ 0.566  Millions$ 0.006  Millions
Achari Ventures Holdings Corp I  89.94 $ 398.783  Millions$ 4.434  Millions
Eternity Healthcare Inc.  79.78 $ 0.049  Millions$ 0.001  Millions
United Health Products Inc   73.09 $ 0.205  Millions$ 0.003  Millions
Theravance Biopharma inc   64.97 $ 39.666  Millions$ 0.611  Millions
Nektar Therapeutics  64.23 $ 210.965  Millions$ 3.285  Millions
Lexicon Pharmaceuticals Inc   60.81 $ 24.216  Millions$ 0.398  Millions
Grapefruit Usa Inc   59.12 $ 0.210  Millions$ 0.004  Millions
Sonida Senior Living Inc   56.36 $ 404.808  Millions$ 7.182  Millions
Adamas Pharmaceuticals Inc  54.97 $ 31.693  Millions$ 0.577  Millions
Acadia Pharmaceuticals Inc   54.96 $ 47.044  Millions$ 0.856  Millions
Oragenics Inc   50.63 $ 1.156  Millions$ 0.023  Millions
Nature s Sunshine Products inc   45.58 $ 331.374  Millions$ 7.271  Millions
Lifevantage Corp  41.10 $ 184.055  Millions$ 4.478  Millions
Biorestorative Therapies Inc   39.98 $ 0.510  Millions$ 0.013  Millions
Acura Pharmaceuticals inc  38.32 $ 6.437  Millions$ 0.168  Millions
Advanced Container Technologies Inc   36.10 $ 1.238  Millions$ 0.034  Millions
Merrimack Pharmaceuticals Inc  35.78 $ 101.745  Millions$ 2.844  Millions
Ionis Pharmaceuticals Inc   35.29 $ 316.993  Millions$ 8.982  Millions

Date modified: 2026-06-22T14:31:56+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.